key: cord-0882310-ak1sby9j
authors: Siwczak, Fatina; Loffet, Elise; Kaminska, Mathilda; Koceva, Hristina; Mahe, Maxime M.; Mosig, Alexander S.
title: Intestinal Stem Cell-on-Chip to Study Human Host-Microbiota Interaction
date: 2021-12-06
journal: Front Immunol
DOI: 10.3389/fimmu.2021.798552
sha: c38ba6195dd4ef5a2e08610cc793fe9b6d8dbff2
doc_id: 882310
cord_uid: ak1sby9j

The gut is a tubular organ responsible for nutrient absorption and harbors our intestinal microbiome. This organ is composed of a multitude of specialized cell types arranged in complex barrier-forming crypts and villi covered by a mucosal layer controlling nutrient passage and protecting from invading pathogens. The development and self-renewal of the intestinal epithelium are guided by niche signals controlling the differentiation of specific cell types along the crypt-villus axis in the epithelium. The emergence of microphysiological systems, or organ-on-chips, has paved the way to study the intestinal epithelium within a dynamic and controlled environment. In this review, we describe the use of organ-on-chip technology to control and guide these differentiation processes in vitro. We further discuss current applications and forthcoming strategies to investigate the mechanical processes of intestinal stem cell differentiation, tissue formation, and the interaction of the intestine with the microbiota in the context of gastrointestinal diseases.

The gastrointestinal tract is a central organ system that enables the ingestion, digestion, absorption, and the utilization of processed nutrients to fuel the overall body. Within this system, several organs are responsible for digestion and the uptake of nutrients, including the stomach, the small intestine, and the large intestine. The gut forms a tubular structure whose central lumen is enclosed by a protective mucosa composed of a monostratified epithelium forming invaginations (or crypts) and finger-like protrusions (or villi). The epithelium allows nutrient uptake and acts as the first line of protection against invading pathogens (1) . A crypt-villus structure is seen in the small intestine, while only crypts are present within the colon. Both the initial development and continuous selfrenewal of the intestinal epithelium are guided by niche signals in addition to cell-autonomous processes that initiate the outgrowth and differentiation of intestinal stem cells (ISCs), driving proliferation and differentiation along the crypt-to-villus axis in the small intestine. Transitamplifying cells derived from ISC further separate into lineages showing absorptive or secretory characteristics that terminally differentiate into specific cell types within the epithelium (2) . Enterocytes are the predominant cell type in the epithelium and involved in the absorption and transport of small molecules from the intestinal lumen into the bloodstream. Enterochromaffin cells, a enteroendocrine cell type, are specialized cells of the epithelial tissue that secrete hormones and modulate neural activity by releasing neurotransmitters (3) . Microfold cells (M cells) are responsible for the transport of luminal antigens to the lymphoid follicles, thereby initiating an adapted immune response to the microbiota (4) . The composition of the microbiota at the epithelium can be modulated by Paneth cells through secretion of antimicrobial peptides. In addition, this cell type contributes to the maintenance of the ISC niche (5) . Tuft cells and cup cells belong to the rarer cell types of the intestinal epithelium. For Tuft cells, a contribution to neural signaling has been proposed (6) whereas the function of cup cells still awaits clarification. This complex epithelium composed of several cell types is surrounded by smooth muscle cell layers, the enteric nervous system, and connective tissue that contains arteries and lymphatics and is abundant in fibroblasts and mast cells (7) .

The last few decades in biomedical research have led to a number of robust experimental strategies and techniques to study intestinal physiology. Yet, in vitro studies aiming to model the gut mucosa have mostly been limited to static monocultures and cocultures. In contrast to these older models, recent developments that use microphysiological systems allow scientists to probe both the intestinal epithelium and its environment in a dynamic and physiologically relevant manner (8) . In this review, we will emphasize the transitions from immortalized cell lines to stem cells and describe their use in combination with gut-on-chip models. These "on-chip" models are defined as three-dimensional (3D) cell cultures arranged as multiple cell layers actively perfused by microfluidics for medium exchange to enable an improved tissue formation with increased lifespan. We will highlight selected applications of these gut-on-chip models to understand gastrointestinal diseases and forthcoming strategies to investigate human gut physiology.

The recapitulation of whole embryonic development can be challenging due to a lack of knowledge of all the required biochemical cues driving the differentiation and morphogenic processes. One of the most novel in vitro approaches in intestinal mucosa modeling is the use of microfluidically perfused organon-chip seeded with cell lines, primary cells, or stem cells (9) (10) (11) (12) (13) (14) . A clear benefit of these models is that they allow for better control of the microenvironment. One example includes the addition of flow on Caco-2 cells to differentiate them and express the typical cell markers of essential cell types of the small intestine (Gobletand Paneth-, enterochromaffin-, and enterocytes) (15) . Further, flow conditions stimulated an increased expression of mucin-2 with the development of a thickened mucus layer covering the epithelial tissue, indicating the functional relevance of flow conditions for improved goblet-like cell functionality (9, 16) . Perfused organ-on-chip further facilitates physiological cellular crosstalk by aiding in the outgrowth of organotypic microstructures such as villi and crypts (9, 12) . In addition, an epithelial cell layer has been combined in a number of studies with endothelial cells and immune cells using various tissue engineering approaches (9, 12, 17) . These studies highlight the potential of organ-on-chip as a tool to manipulate the microenvironment by facilitating the long-term growth and codifferentiation of different cell types to replicate some typical microanatomical features of the human intestine.

Immortalized cell lines have been used extensively to study the intestine. For example, the colorectal adenocarcinoma cell line Caco-2 had been originally used to study the intestinal epithelial barrier as these cells differentiate spontaneously into a monolayer of enterocytes when reaching confluence (18) . However, given the cancerous background of the Caco-2 cell line data generated with these models, the data should be interpreted with caution as this cell line has several limitations in its differentiation potential to individual intestinal cell types compared to adult stem cells or induced pluripotent stem cells (19) . Further, immortalized cell lines such as Caco-2 cannot reflect a patient-specific genetic background to enable a personalized approach to study individual mechanisms of disease-related conditions.

To overcome these limitations, the use of human pluripotent stem cells (hiPSCs) or adult stem cells has been explored as a promising alternative to established cell lines. Human adult ISCs maintain an organ-specific imprint and epithelial maturity and possess a patient-specific background, thus enabling personalized studies (9, 14) . Biopsy-derived cells and intestinal organoid models have emerged as powerful tools to mimic tissue complexity and high cellular diversity in vitro (20, 21) . ISCs are a valuable cell source to grow organoids with organotypic selfpatterning, thereby recreating essential microanatomical features of the gut (22) . However, the availability of primary tissue for the isolation of ISCs is limited. Hence, hiPSCs are an exciting alternative as they can generate intestinal cells through directed differentiation (23) . The use of hiPSCs allows for the generation of multiple differentiated cell types from a patient-specific background with an unlimited supply of human stem cells stored in biobanks (24) . Furthermore, hiPSCs from patients with a genetic background of interest can be obtained by reprogramming from a multitude of easily accessible primary cell sources, including urine, blood, and skin (25) . Nevertheless, a significant drawback in using pluripotent stem cells can be found in difficulty producing tissues that reach full maturity.

ISC-derived organoids have been used to experimentally address and dissect the individual spatiotemporal effects of different biochemical gradients on the growth and differentiation of ISCs. However, given the spherical nature of organoids, the stable recreation of physiological conditions over a more extended period of culture has remained challenging (26) . Microfluidically perfused organ-on-chip platforms mimic in vivo-like biochemical cues to guide stem cell differentiation with typical microanatomical features such as villi and crypts ( Figure 1 ).

It has been long known that many aspects of cell fate are dependent on the geometry and mechanics of their microenvironment, including the induction of apoptosis (27) , cellular differentiation (28, 29) , and proliferation rate (30) . The presence of a flow-through media stream has been demonstrated to be a requirement for forming 3D intestinal structures in cell lines and primary cell-based intestinal models by modulating the biochemical availability of growth factors. The flow-dependent basolateral removal of the Wnt antagonist Dickkopf-1 and the elevated expression of the Frizzled-9 receptor was required in the formation of epithelium villi-like protrusions (31) . Our existing knowledge on the individual growth factors driving ISC differentiation provides an excellent basis to engineer more realistic organ models with better accessibility. In this review, we are focusing on the use of the following two principal types of stem cells to differentiate and form intestinal tissue: adult stem cells and induced pluripotent stem cells. Both cell sources possess unique advantages and disadvantages in recapitulating the intestinal tissue ( Table 1) .

A striking example of the potential of defined growth factor gradients to guide stem cell growth to intestinal tissues has been given by Wang et al. in the Transwell system (34, 35) . Arrays of artificial collagen-based crypts and villi structures were created by microfabrication and molding to mimic the topography of the intestine and the colon (34, 35) . The scaffold has been used to generate gradients of Wnt-3A, R-spondin, noggin, and gammasecretase inhibitor. These gradients enabled the establishment and maintenance of a crypt-villus axis composed of adult human ISCs that formed an epithelium containing proliferating progenitor cell compartments. Kasendra et al. recently presented a more complex model of the human duodenum that combines the advantages of organoids and organ-on-chip technologies (9, 36) . In this model, the tissue forms a polarized cell architecture under flow conditions and shows improved intestinal barrier function and differentiation of specialized cell subpopulations. This duodenum-on-chip system could exert mechanical stimulation to organoid-derived epithelial cells, resulting in improved tissue architecture. The tissue perfusion significantly improved cell-cell junctions and microvilli density, further improving intestinal barrier function. Remarkably, it was demonstrated that organoid-derived cells in the duodenum chip have an increased similarity in their global gene expression profile to human adult duodenal tissue compared to conventional static organoid culture. Further, in the duodenum-on-chip system, organoid-derived cells show an improved metabolic capacity compared to Caco-2 cells due to an increased induction capability and expression of CYP3A4 (36) .

The ability to integrate and analyze patient-specific stem cells from different donors within the chip represents a decisive advantage over the use of immortalized cell lines such as Caco-2 or HT-29. Stem cells allow for the reflection of the host's genetic background and possess the ability to self-organize into an in vivo-like tissue structure with improved functionality. Both aspects are significant assets for studies on drug uptake and drugdrug interaction and its metabolization to predict drug efficacy and safety. Recently, Nikolaev et al. used synthetic hydrogels to guide the growth of adult human ISCs with intrinsic selforganization properties to tubular structures forming cryptand villus-like domains (37) . Furthermore, conventional organoids and 2D cell layers derived from intestinal organoids possess a high regenerative potential when cultured on hydrogels, as demonstrated after stimulation with cytotoxic dextran sodium sulfate (DSS) to model colitis. The perfusion of the system was used to provide a continuous supply of nutrition and the removal of waste products and dead cells, allowing the formation of a tenfold higher cell mass and the emergence of rare cell types such as M cells (37). Similar approaches have also been demonstrated using hiPSCs. Workman et al. used epithelial cells isolated from hiPSC-derived human intestinal organoids and seeded them in a microfluidic perfused gut-on-chip. In the 3D tissue model, the spontaneous differentiation into epithelial-specific types, such as Paneth cells, goblet cells, enterocytes, enteroendocrine cells, transit-amplifying cells, and Lgr5+ cells similar to in vivo cell populations was observed under flow conditions (38) . The immune responsiveness of the intestinal tissue after INFg stimulation was validated by the measurement of STAT1 phosphorylation after one hour and the upregulation of INFg−related genes three days after stimulation. Further, combined treatment with INFg and TNF resulted in increased permeability of the epithelial cell layer. In another study, the same chip platform was used to culture stem cell-derived epithelial cells isolated from human colon organoids (14) . Likewise, the OrganoPlate system, a plate-based cell culture system that allows pumpless media movement via a rocking platform, was used for cultivating hiPSC on a gel matrix to form a monolayered epithelial tube (39) . The cells expressed the Paneth cell marker Lysozyme, the enterocyte cell marker Villin-1, and the neuroendocrine cell marker Chromogranin A. However, the expression of these cell marker proteins was diffuse and distributed over the entire tissue. Another shortcoming of the model is the absence of organized 3D epithelial structures.

These gut-on-chip systems strikingly demonstrate the vast potential of organ-on-chip platforms to precisely control environmental growth conditions, to guide the differentiation of stem cells, and to form improved intrinsically self-organized tissue with superior properties compared to traditional organoid cultures. Hence, the applications of ISCs include the possibility to investigate intestinal developmental biology and barrier function but also studies related to bacterial colonization, drug discovery, regenerative medicine, and responses to infections in a personalized approach (40) (41) (42) (43) . The generation and integration of hiPSC-derived immune cells such as T cells, NK cells, and macrophages by use of differentiation protocols that became recently available will aid in the development of isogenic immune-competent intestinal models derived from a single hiPSC line to avoid potential allogenic reactions (44) (45) (46) .

As a result of coevolution, niches of the human body are inhabited by a variety of commensal, mutualistic, and pathogenic microorganisms, including archaea, bacteria, fungi, phages, protists, and viruses (47) (48) (49) (50) (51) (52) (53) . The gut provides a variety of niches serving as habitats for different ecological communities. On a macroscopic scale, physiological gradients determine the growth niche of microorganisms along the gut from the small intestine toward the rectum with an increase in the pH and the abundance of bile acids, whereas the availability of oxygen decreases. A change in the environmental conditions thereby determines microbial colonization with 10 4 CFU/ml bacteria in the small intestine up to 10 8 CFU/ml microorganisms in the terminal ileum, where elongated passage times and associated enrichment in nutrients provide ideal bacterial growth conditions (54, 55) . With that, the number of facultative anaerobic and obligate anaerobic species increases from the small intestine to the colon (56, 57) .

Toll-like receptors (TLR) belong to a class of pattern recognition receptors evolutionary highly conserved and centrally involved in mediating host-microbe interactions in epithelial cells (58) . Recent studies provide evidence of a defined spatial organization of TLR expression along the gut axis, which seems to be determined already before birth in tissueresident stem cells and is only partially dependent on the interaction with the commensal gut microbiota (59, 60) . TLR dependent pathways have been shown to mediate not only antimicrobial functionality but also directly contribute to the regulation of epithelial cell differentiation, which is of particular importance for the intestine (61) . LPS activation of TLR-4 enhances cell differentiation of goblet cell lineages in colonic organoids but inhibits Lgr5+ proliferation with induction of apoptosis in stem cells. Similar observations have been made in intestinal organoids (62) . MyD88 is an essential adapter protein to TLR-4 and critically involved in mediating LPS dependent maintenance of mucus production. Consequently, MyD88-/mice have impaired mucus production with increased bacterial adherence to epithelial cells and loss of barrier function (63) . TLR activation has also been demonstrated to contribute to the polarization of IECs depending on the side of stimulation (64) . A strict unique spatial distribution pattern of TLRs between the apical or basolateral side of IECs along the gut axis contributes to an adapted interaction with the microbiota as a requirement for the maintenance of barrier functionality (65, 66) . The proof of a physiological TLR distribution pattern in IECs cultured in gut-on-chip models remains an open task, but likely represents an important requirement to faithfully recapitulate host-microbiota interaction in vitro. IECs derived from different gut sections cultured in gut-on-chip and precisely stimulated with TLR agonists in a precise spatiotemporal manner by microfluidic perfusion would offer an interesting approach for achieving a physiologically relevant TLR expression pattern in vitro. Recent work already demonstrated the feasibility of a similar approach to achieve intestinal tissue polarization in an immunocompetent gut-on-chip model. Monocyte derived macrophages and dendritic cells here instructed immune tolerance and the maintenance of barrier function depending on the site of LPS stimulation (12) .

The reliable monitoring of the microenvironment and its change upon tissue formation or bacterial colonization is key to control and understand the stem cell development and differentiation as well as the interaction of the intestinal tissue with the microbiota. Luminescent-based sensors integrated into organ-on-chip systems have been used to quantify medium dissolved oxygen levels (67, 68) , cellular glucose consumption (69) , and the changes of the pH by the release of lactate by metabolic active tissues or microorganisms (70) (71) (72) . To enable the growth of anaerobic bacteria in gut-on-chip, several platforms have been tailored to allow the stable formation of neighboring cell layers perfused with normoxic and hypoxic media streams. The characterization and quantification of microbiota-associated changes in the metabolic profile require reliable and continuous measurement of key metabolites and mediators of microbial colonization. Electrochemical enzymebased biosensors and microbead-based microfluidic assays expand the ability of organ-on-chip systems to perform detailed monitoring of metabolic parameters, including the formation of glutamine and glutamate (73, 74) , the release of reactive oxygen species (75) , and the secretion of various cytokines (76, 77) . The determination of transepithelial electrical resistance (TEER) is another widely used method to assess barrier function and has been adapted in recent years for organ-on-chip platforms. In particular, the combination of impedance spectroscopy and electrical stimulation has been used to quantify cell layer capacitance as a measure of villi differentiation in gut-on-chip models, which could be applied across different gut-on-chip platforms (78) .

Gut-on-chip models have been used in recent years to better understand the complex interactions between the microbiota and their host. These systems allow balancing between robust and predictable approaches and the recreation of physiologicalrelevant culture conditions (Figure 2) . The incremental nature of these models makes it relatively simple for them to be designed as "simple as possible and complex as required," and they, therefore, offer additional flexibility in identifying contributing factors of hostmicrobiota interaction. The controlled escalation of biological complexity on the host side as well as in the composition of microbiota-derived factors and live microorganism communities will enable the elaboration and the proof of a complex interaction mechanism in a well-controlled and standardized environment provided by organ-on-chip platforms (Figure 3 ).

Examples of a successful application of this approach have already been provided. Sontheimer-Phelps et al. recently reported a system lined with primary patient-derived colonic epithelial cells (14) . A mucus bilayer is built up in the chip by perfused epithelial cells and provides a suitable substrate for colonization with living microbiota to study host-microbiome interactions in the colon in more detail. Similarly, Shin et al. generated an anoxic-oxic interface on a chip inhabited with CaCo 2-cells and implemented Bifidobacterium adolescentis (79). The system is able to co-cultivate bacteria for up to one week without the impairment of epithelial performance. This represents an interesting platform to assess mechanistic questions regarding Bifidobacteria-host interactions in the neonate period in more detail. Similarly, Zhang et al. reported the co-culture of the obligate anaerobic bacterium Faecalibacterium prausnitzii with colon organoid-derived epithelial cells in their physiomimetic platform for up to four days. In the study, the authors were able to uncover the mechanisms of an anti-inflammatory host response related to butyrate release with the downregulation of the gene expression of histone deacetylase complexes, Toll-like receptors, and nuclear factor kB (NF-kB) (80) . Different approaches have also been used to reconstitute the microbiome and its function in vitro in a more complex and detailed manner. A top-down approach consists of using the full microbiome derived from human stool samples, which would, in principle mimic the in vivo situation ideally. However, it remains challenging to characterize its full composition in a short period of time before transfer into an in vitro model, even under hypoxic conditions. Jalili-Firoozinezhad and co-workers managed to implement complex microbiomes in their in vivo-like system but pointed out that overgrowth and species shift due to artificial culture conditions might be problematic. Thus, a sophisticated pre-culture step (i.e., in large SHIME bioreactors) is still required to expand a defined microbiota prior to colonization experiments (11) . However, these studies illustrate nicely the potential of advanced in vitro models to dissect the individual microbiota in humans.

Although conventional organoid cultures already provide invaluable insight into detailed ISC dynamics, their application for long-term studies or the dissection of host-microbiota interaction has some limitations. The long-term exposure of microbial metabolites or co-culturing living microorganisms in an enclosed lumen of organoids under static conditions favors the rapid overgrowth of bacteria, eventually resulting in the rupture and cell death of the organoids (32, 81) . The microfluidic perfusion of guton-chip offers the ability of the long-term exposure of the tissue to microbiota-associated metabolites under well-defined conditions. Perfusion media can be supplemented with defined single molecules of microbial metabolites up to filtrates of stool samples, single strain microorganisms, or defined microbial communities. To better recapitulate the in vivo situation, gut-on-chip platforms could be leveraged to mimic the conditions of different sides of the gut by use of adult stem cells derived from specific sections (i.e., intestine, colon, etc.) to generate side-specific tissue ( Table 2) . Colonization with oxygen-scavenging bacteria in combination with the continuous sensing and regulation of oxygen levels would allow the maintenance of physiological-relevant oxygenation levels and a co-culture with defined anaerobic and facultative-anaerobic bacteria under homeostatic conditions.

Gut-on-chip models offer a new avenue through which to study the pathophysiological mechanisms of gastrointestinal diseases. For example, patients suffering from Celiac disease (CeD), an autoimmune disease that affects about 1% of the human population, develop a strong inflammatory response causing severe damage to the small intestine upon the uptake of a glutencontaining diet (82) . Still, the mechanistic details of the disease await further investigation before effective drugs can be developed. Moerkens et al. recently proposed an immunocompetent organon-chip model using both hiPSC and primary epithelial cells to mimic the genetic background and environmental factors more reliably. Using this system, it is now possible to determine the disease onset in CeD patients (83) . Similarly, gut-on-chip models have been used to study the disease mechanism of inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), characterized by chronically relapsing intestinal inflammation and representing a worldwide healthcare problem with continually increasing incidence (84) . A 3D gut model based on primary patient-derived colonic epithelial cells forming a mucus layer was used to recapitulate prostaglandin E2-dependent mucus volume expansion via the activation of the Na-K-Cl cotransporter 1 ion channel (14) . In a similar study, the pathophysiology of DSS-induced inflammation was also recapitulated in the presence of E. coli (16) . DSS cessation quickly induced the recovery of barrier integrity, villus formation, and mucus production, indicating that this model might also be suitable to study processes of mucosal regeneration in IBD. The effects of microbial colonization were also investigated with a mixture of commensal Streptococcus thermophilus, Bifidobacteria, and Lactobacilli (VSL#3) as well as pathogenic enteroinvasive E. coli (EIEC). In this study, the authors were able to replicate inflammation-associated tissue damage and the invasion of EIEC. Furthermore, they proved the growth-limiting effect of VSL#3 on EIEC colonization in vitro (85) . Recently, our group has been able to further replicate the protective characteristics of Lactobacillus rhamnosus against the tissue infiltration of the opportunistic yeast Candida albicans in an immunocompetent gut-on-chip model. In addition to peripheral immune cells, this model also contained functional mucosal macrophages and dendritic cells integrated into the epithelial tissue layer (12) . In contrast to conventional organoid cultures, chip-based ISC cultures enable long-term studies and perfusion with peripheral immune cells with superior accessibility and the continuous monitoring of key environmental factors to maintain and manipulate disease-related growth conditions. In combination with a homeostatic bacterial co-culture, these systems might serve in future studies as patient-specific tools to develop new therapeutics or probiotics that modulate the mucus barrier.

Gut-on-chip has further been used to study infectious diseases, including Clostridioides difficile infection (CDI), Enterohemorrhagic E. coli (EHEC), and viral infections. Infection with Clostridioides difficile (formerly Clostridium difficile) is the most common cause of hospital-acquired gastrointestinal infections (86, 87) . While several animal models have been used to study CDI in vivo, the manipulation of infection processes and the direct assessment of host-bacterial interaction is challenging (88) (89) (90) . Advanced gut-on-chip models have been described to investigate CDI. This model allows for the co-culture of primary epithelial and endothelial cells, with the addition of a complex microbiome under anaerobic culture conditions for several days (11) . This is a promising translational tool to study the CDI infection process and associated damage in humans. As with CDI, infections with EHEC are frequent, with up 100,000 cases per year in the U.S. and are associated with several symptoms such as severe bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS). Interestingly, the microbiota seems to be a critical determinant of susceptibility to EHEC infection. Studies in mice revealed that not only is a 100,000-fold higher dose of the bacterium required (10 7 microbes) but that the whole murine microbiome also needs to be depleted to induce symptoms. This pathology is quite different in humans, where as little as 10 2 microbes are sufficient to cause severe symptoms (91) (92) (93) . With the emergence of the SARS-CoV2 virus and the COVID-19 pandemic, the need for sophisticated models to study viral infection in human tissue has become even more urgent. Human small intestinal organoids have proven to be valuable tissue models to study virus docking to angiotensin converting enzyme II and its replication within enterocytes. Combining ISC-derived organoids with the advantages of organ-on-chip would offer additional options to manipulate the viral infection route and provide different parameters to faithfully reflect the intestinal microenvironment, prolong the culture of organoids with the improvement of cellular differentiation, and offer a variety of additional monitoring and readout techniques available for gut-on-chip systems (96) .

The effects of short-chain fatty acids (SCFAs) released by probiotic Lactobacillus rhamnosus GG (LGG) bacteria on the growth of colorectal cancer cells was recently investigated in a version of the HuMiX model, a modular, microfluidics-based gut-on-chip model, which allows the co-culture of human and microbial cells and facilitates anaerobic culture conditions (97) . Symbiotic treatment with a high-fiber diet was simulated in this model, and the generation of organics and SCFAs was assessed. Strikingly, it was demonstrated that SCFAs and lactate production was altered by a simulated high-fiber diet compared to a reference diet medium containing only simple sugars. The simulated high-fiber diet caused an increased expression of oncogenes and proinflammatory signaling in the absence of LGG bacteria, whereas, in the presence of LGG, both gene clusters were found to be significantly downregulated and associated with a reduced cell proliferation rate of primary colonrectal cancer cells. This study illustrates the capability of gut-onchip systems to precisely dissect the individual aspects of the microbiota-host crosstalk at the metabolic level. Hopefully, similar studies will further expand our insight into this complex relationship by identifying individual metabolic targets with potential as tailored pre-and probiotic-based therapeutic options. Uncovering individual beneficial metabolic profiles by applying hiPSC-based organ models and individualized microbiota surrogates in personalized in vitro models would represent a major step forward in the treatment of IBD and IBD sequelae such as colorectal cancer.

The intestinal tissue shows considerably variance in its architecture, cellular and molecular composition along the cephalocaudal axis, thereby creating various defined environmental niches populated with a specifically adapted microbiota (54, 60, 98) . These niches are defined by differences in biophysical cues such as luminal oxygen levels or changes in pH and formed by adapted epithelial cells. Future gut-on-chip systems should be able to recapitulate this topography and allow the direct monitoring of environmental changes i.e., induced by changes in the microbiota composition and its impact on drug metabolization. It has been demonstrated that chip-based cultivation of organoid-derived cells could accelerate the formation of a self-organized epithelial microarchitecture, allowing the long-term culture with a living microbiota (11, 37, 79) . These models have already proven to produce data similar to in vivo contexts in studies ranging from infectious disease modeling to drug metabolism (12, 13, 36, 41, 42, 94) . The benefits and wide range of applications of the gut-on-chip models can be attributed to their versatility and their capability to increment parameters of various types, from multiple cell types to medium gradients, flow mechanics, or global topography. Despite these numerous advances in the complexification of microfluidics systems, many requirements still need to be met in order to obtain models with an in vitro microenvironment that closely mimics its in vivo counterpart. Gut-on-chip technology offers unique options by providing the technical basis for a reliable and guided differentiation of stem cells to human intestinal tissue, combining the strengths of self-patterned stem-cell-based organoids with the ability to precisely regulated biochemical and biophysical cues in a spatiotemporal manner. The manipulation of the microenvironment by tissue engineering and the guided growth of stem cells derived from patients will create a new angle for the dissection of personalized host-microbiota interaction with scalable levels of complexity for the host and the microbiota. Optimizing fully defined and tunable hydrogel matrices as an alternative to the widely used Matrigel will allow the generation of organoids in a more standardized and reproducible way as a reliable cell source for gut-on-chip systems. Promising approaches have already demonstrated the potential of novel synthetic polymer matrices based on alginate (99) , thrombin cross-linked fibrin gels (100) or PEG macromers decorated with maleimide groups (101) .

The combination of advanced cell substrates and the precise control of differentiation conditions offered by microfluidic perfusion has great potential for improving stem cell differentiation and maturation to faithfully mimic epithelial cell layers (37) . With the ability to monitor and perturb the milieu by manipulating isolated biophysical and biochemical cues in real-time these systems provide a deeper mechanistic insight into stem cell differentiation and effects of changes in the microenvironment on tissue formation its interaction with the microbiota. Further, gut-on-chip will help identify the molecular and cellular targets of disease-related mechanisms for individual patients that cannot be resolved in similar detail in animal models. Improvements of the materials used for chip manufacturing will also increase its relevance for drug testing. Polydimethylsiloxane so far widely used for organ-on-chip is known to non-specifically bind small hydrophobic molecules, which potentially causes bias in drug-absorption and metabolization studies (102, 103) . Advanced microfabrication processes using i.e., thermoplastic polymers with more inert properties, will foster the acceptance of gut-on-chip models for drug screening (104) .

Clearly, organ-on-chip and in particular complex gut-on-chip models have several limitations. In contrast to conventional organoid cultures, their usability in high-throughput testing is limited.

The ORCHID consortium thus elaborated recommendations for the development and use of future organ-on-chip models as part of a European Roadmap (105) . End users need to be provided with customizable platforms "fit-for-purpose" and provided with tailored training programs. ISC-based gut-on-chip as well as ISCderived organoids represent reductionistic models, which do not reflect the full physiology offered by animal models. Currently available systems thus need to be selected based on the scientific context of the study i.e., the pathogen that is studied or its targeted cell type. The use of standardized and open platform technology will benefit in the future by the establishment of independent testing centers for the qualification and characterization of organon-chip models (105) .

In the case of organ-on-chip modeling of the gastrointestinal tract, a more "complete" model would need to be composed of adjacent channels with human microvascular endothelium, tissueresident immune cells, commensal or pathogenic bacteria, and the application of cyclic mechanical forces that mimic peristalsis-like deformations. The additional presence of muscle or nervous system cells could also contribute to create such a faithful model. To this date, there is no system available which is capable to recapitulate every aspect of the gut, considering biophysical, biochemical, immunological and microbiota derived cues. However, the combination of stem cell-based organoid culture and organ-on-chip will help pave the way to significantly expand our knowledge in the development and maintenance of intestinal tissue and its role in the onset of related diseases. Several challenges, such as the uniformization of the systems and its standardization, need to be overcome to allow researchers and non-organ-on-chip specialists easy access to this technology and to allow its routine use in biomedical research.

FS, EL, MK, HK, MM, and AM contributed to the writing of the manuscript. MM and AM conceptualized, supervised, and edited the manuscript. All authors contributed to the article and approved the submitted version.

This work was financially supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Balance of the Microverse" under Germany's Excellence Strategy -EXC 2051 -Project-ID 690 390713860 and the European Commission through the Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network EUROoC (Grant no. 812954) to AM. This work was also supported by the Agence Nationale de la Recherche ANR-17-CE14-0021 (SyNEDI to MM) and a "New Team" grant (BOGUS to MM) from the Bioregate Regenerative Medicine Cluster, University of Nantes and Reǵion Pays de la Loire.

Gut Integrity in Critical Illness

The Intestinal Crypt, A Prototype Stem Cell Compartment

The Specification and Function of Enteroendocrine Cells in Drosophila and Mammals: A Comparative Review

The Roles of Peyer's Patches and Microfold Cells in the Gut Immune System: Relevance to Autoimmune Diseases

Secretory Sorcery: Paneth Cell Control of Intestinal Repair and Homeostasis

Long-Lived Intestinal Tuft Cells Serve as Colon Cancer-Initiating Cells

Anatomical Basis of Tolerance and Immunity to Intestinal Antigens

Chip Models: New Opportunities for Biomedical Research

Development of a Primary Human Small Intestine-On-a-Chip Using Biopsy-Derived Organoids

A Multi-Chamber Microfluidic Intestinal Barrier Model Using Caco-2 Cells for Drug Transport Studies

A Complex Human Gut Microbiome Cultured in an Anaerobic Intestine-on-a-Chip

A Three-Dimensional Immunocompetent Intestine-on-Chip Model as In Vitro Platform for Functional and Microbial Interaction Studies

Human Colon-On-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology

Gut-On-a-Chip Microenvironment Induces Human Intestinal Cells to Undergo Villus Differentiation

Intestinal Barrier Dysfunction Orchestrates the Onset of Inflammatory Host-Microbiome Cross-Talk in a Human Gut Inflammation-on-a-Chip

Microfabrication of Human Organs-on-Chips

The Caco-2 Cell Monolayer: Usefulness and Limitations

Move Over Caco-2 Cells: Human-Induced Organoids Meet Gut-On-a-Chip

Modeling Development and Disease With Organoids

Cell Fate Specification and Differentiation in the Adult Mammalian Intestine

Organoids: Avatars for Personalized Medicine

Directed Differentiation of Human Pluripotent Stem Cells Into Intestinal Tissue In Vitro

Human iPSC Banking: Barriers and Opportunities

A Decade of Transcription Factor-Mediated Reprogramming to Pluripotency

Bioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche

Geometric Control of Cell Life and Death

Matrix Elasticity Directs Stem Cell Lineage Specification

Role of YAP/TAZ in Mechanotransduction

Materials as Stem Cell Regulators

Human Intestinal Morphogenesis Controlled by Transepithelial Morphogen Gradient and Flow-Dependent Physical Cues in a Microengineered Gut

Human Organoids: Model Systems for

The Mutational Impact of Culturing Human Pluripotent and Adult Stem Cells

A Microengineered Collagen Scaffold for Generating a Polarized Crypt-Villus Architecture of Human Small Intestinal Epithelium

Formation of Human Colonic Crypt Array by Application of Chemical Gradients Across a Shaped Epithelial Monolayer

Duodenum Intestine-Chip for Preclinical Drug Assessment in a

Homeostatic Mini-Intestines Through Scaffold-Guided Organoid Morphogenesis

Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips

Direct On-Chip Differentiation of Intestinal Tubules From Induced Pluripotent Stem Cells

Persistence and Toxin Production by Clostridium Difficile Within Human Intestinal Organoids Result in Disruption of Epithelial Paracellular Barrier Function

Colonic Organoids Derived From Human Induced Pluripotent Stem Cells for Modeling Colorectal Cancer and Drug Testing

Efficient Generation of Small Intestinal Epithelial-Like Cells From Human iPSCs for Drug Absorption and Metabolism Studies

Using Multi-Organ Culture Systems to Study Parkinson's Disease

Development of Innate Immune Cells From Human Pluripotent Stem Cells

Optimised Generation of iPSC-Derived Macrophages and Dendritic Cells That Are Functionally and Transcriptionally Similar to Their Primary Counterparts

A Clinically Applicable and Scalable Method to Regenerate T-Cells From iPSCs for Off-the-Shelf T-Cell Immunotherapy

Idiopathic Destructive Arthritis of the Shoulder

Evolution of Mammals and Their Gut Microbes

A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing

Microbial Eukaryotes in the Human Microbiome: Ecology, Evolution, and Future Directions

Early Life Dynamics of the Human Gut Virome and Bacterial Microbiome in Infants

Strains, Functions and Dynamics in the Expanded Human Microbiome Project

Fungi as Part of the Microbiota and Interactions With Intestinal Bacteria

Gut Biogeography of the Bacterial Microbiota

The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions

Microflora of the Human Small Intestine

Molecular Analysis of Jejunal, Ileal, Caecal and Recto-Sigmoidal Human Colonic Microbiota Using 16S rRNA Gene Libraries and Terminal Restriction Fragment Length Polymorphism

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

A Map of Toll-Like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial

Location-Specific Cell Identity Rather Than Exposure to GI Microbiota Defines Many Innate Immune Signalling Cascades in the Gut Epithelium

Epithelial Toll-Like Receptors and Their Role in Gut Homeostasis and Disease

Microbial Recognition Regulates Intestinal Epithelial Growth in Homeostasis and Disease

Targeted Deletion of MyD88 in Intestinal Epithelial Cells Results in Compromised Antibacterial Immunity Associated With Downregulation of Polymeric Immunoglobulin Receptor, Mucin-2, and Antibacterial Peptides

Apical TLR Ligation of Intestinal Epithelial Cells Drives a Th1-Polarized Regulatory or Inflammatory Type Effector Response In Vitro

Compartmentalizing Intestinal Epithelial Cell Toll-Like Receptors for Immune Surveillance

Interplay Between Microbiota, Toll-Like Receptors and Cytokines for the Maintenance of Epithelial Barrier Integrity

A Microfluidically Perfused Three Dimensional Human Liver Model

A Microfluidics-Based In Vitro Model of the Gastrointestinal Human-Microbe Interface

In-Situ Measurement of Cellular Microenvironments in a Microfluidic Device

A Microfluidic Optical Platform for Real-Time Monitoring of pH and Oxygen in Microfluidic Bioreactors and Organon-Chip Devices

Accessing 3D Microtissue Metabolism: Lactate and Oxygen Monitoring in Hepatocyte Spheroids

Microsensor Systems for Cell Metabolism -From 2D Culture to Organ-on-Chip

Chip-Based Amperometric Enzyme Sensor System for Monitoring of Bioprocesses by Flow-Injection Analysis

Electrochemically Deposited Iridium Oxide Reference Electrode Integrated With an Electroenzymatic Glutamate Sensor on a Multi-Electrode Array Microprobe

Electrochemical Biosensors for on-Chip Detection of Oxidative Stress From Cells

Photonic Lab-On-a-Chip for Rapid Cytokine Detection

A Fluorescent Microbead-Based Microfluidic Immunoassay Chip for Immune Cell Cytokine Secretion Quantification

Non-Invasive Sensing of Transepithelial Barrier Function and Tissue Differentiation in Organs-on-Chips Using Impedance Spectroscopy

A Robust Longitudinal Co-Culture of Obligate Anaerobic Gut Microbiome With Human Intestinal Epithelium in an Anoxic-Oxic Interface-On-a-Chip

Primary Human Colonic Mucosal Barrier Crosstalk With Super Oxygen-Sensitive Faecalibacterium Prausnitzii in Continuous Culture

Organoid Culture Systems to Study Host-Pathogen Interactions

Celiac Disease: A Comprehensive Current Review

Celiac Disease-on-Chip: Modeling a Multifactorial Disease In Vitro

Unravelling the Pathogenesis of Inflammatory Bowel Disease

Contributions of Microbiome and Mechanical Deformation to Intestinal Bacterial Overgrowth and Inflammation in a Human Gut-on-a-Chip

Clostridium Difficile Infection: Review

Microbe-Microbe Interactions During Clostridioides Difficile Infection

A Mouse Model of Clostridium Difficile-Associated Disease

The Role of Toxin A and Toxin B in Clostridium Difficile Infection

Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium Difficile. eLocator

Hemolytic Uremic Syndrome Induced by Lipopolysaccharide and Shiga-Like Toxin

A Murine Model of HUS: Shiga Toxin With Lipopolysaccharide Mimics the Renal Damage and Physiologic Response of Human Disease

Mouse Models of Escherichia Coli O157:H7 Infection and Shiga Toxin Injection

Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro

One Hundred Years of Poliovirus Pathogenesis

SARS-CoV-2 Productively Infects Human Gut Enterocytes

Integrated In Vitro and In Silico Modeling Delineates the Molecular Effects of a Synbiotic Regimen on Colorectal-Cancer-Derived Cells

Organoids and Organs-on-Chips: Insights Into Human Gut-Microbe Interactions

Nonadhesive Alginate Hydrogels Support Growth of Pluripotent Stem Cell-Derived Intestinal Organoids

Growth of Epithelial Organoids in a Defined Hydrogel

Synthetic Hydrogels for Human Intestinal Organoid Generation and Colonic Wound Repair

PDMS Absorption of Small Molecules and Consequences in Microfluidic Applications

New Materials for Organ

Chips for Biomaterials and Biomaterials for Chips: Recent Advances at the Interface Between Microfabrication and Biomaterials Research

Building Blocks for a European Organ-On-Chip Roadmap

this article, or claim that may be made by its manufacturer, is not guaranteed or

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in